GENZ DOES NOT DESERVE THIS p/e. Reuters has an underperform on this stock. Cuts 2009
adjusted earnings per share view to $2.26 per share
* Q3 cerezyme sales fell to $93.6 million from $309.6
million * Q3 fabrazyme... Business & Finance > Investments > Stocks (A to Z) > Stocks G > Genzyme General Division (GENZ)
BAC should be at $3 BAC is funtionally insolvent. It will not pass a stress
test and is being kept on life support by federal
monies. I am a long and am getting out before... Business & Finance > Investments > Stocks (A to Z) > Stocks B > Bank of America Corporation
